Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT
Avalo Therapeutics Revenue
Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending June 30, 2025, Avalo Therapeutics generated $0 in revenue.
Revenue (ttm)
441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
19.17K
Employees
23
Market Cap
119.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 441K | -77.08% |
| Dec 31, 2023 | 1.92M | -89.34% |
| Dec 31, 2022 | 18.05M | +234.40% |
| Dec 31, 2021 | 5.4M | -19.42% |
| Dec 31, 2020 | 6.7M | -0.76% |
| Dec 31, 2019 | 6.75M | -63.17% |
| Dec 31, 2018 | 18.33M | -34.11% |
| Dec 31, 2017 | 27.81M | +2312.24% |
| Dec 31, 2016 | 1.15M | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | -100.00% |
| Dec 31, 2012 | 82.76K | n/a |